Skip to main content

Table 4 Effects of MAPT haplotype and disease status on levels of tau isoforms and α-syn in the soluble protein fraction in human samples of fusiform gyrus and cerebellum

From: Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue

Protein fraction

Brain region

Two-way ANOVA

Main effect of haplotype

Main effect of disease

Haplotype × disease

Direction of significant effect

P value

P value

P value

P value

α-syn

ctx-fg

0.830

0.595

0.511

0.899

–

 

ctx-cbl

0.926

0.563

0.946

0.790

–

Total tau

ctx-fg

0.737

0.279

0.877

0.908

–

 

ctx-cbl

0.285

0.415

0.875

0.077

–

0N3R tau

ctx-fg

0.312

0.101

0.406

0.734

–

 

ctx-cbl

0.207

0.207

0.150

0.205

–

0N4R tau

ctx-fg

0.341

0.103

0.479

0.724

–

 

ctx-cbl

0.301

0.176

0.332

0.251

–

1N3R tau

ctx-fg

0.308

0.093

0.455

0.721

–

 

ctx-cbl

0.412

0.223

0.519

0.263

–

1N4R tau

ctx-fg

0.446

0.145

0.552

0.700

–

 

ctx-cbl

0.480

0.898

0.919

0.132

–

2N3R tau

ctx-fg

0.538

0.653

0.184

0.551

–

 

ctx-cbl

0.581

0.251

0.574

0.610

–

2N4R tau

ctx-fg

0.709

0.316

0.607

0.749

–

 

ctx-cbl

0.072

0.569

0.482

0.052

–

  1. Main effect of haplotype was analyzed by comparison of H1/H1 (Controls + PD) versus H2/H2 (Controls + PD). Main effect of disease was analyzed by comparison of PD (H1/H1 + H2/H2) versus Controls (H1/H1 + H2/H2). The interaction haplotype × disease examined the relationship between the independent variables (haplotype + disease) on the dependent variable of protein levels. P values were calculated using two-way ANOVA followed by Tukey’s multiple comparisons test
  2. ctx-fg, cortex of fusiform gyrus; ctx-cbl, cerebellum.